Ph3 multisite randomized trial of BNT327 in combo with participants with SCLC
Phase III Clinical Trial
A Phase III multisite double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplatin) compared to atezolizumab in combination with chemotherapy (etoposide/carboplatin) in participants with first-line extensive-stage small-cell lung cancer (BNT327-03)
Participating Locations